|
BZW1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96299999999372E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.9673999999954E-05 |
| Normal-vs-Stage2 |
4.42740000000663E-05 |
| Normal-vs-Stage3 |
1.196500E-04 |
| Normal-vs-Stage4 |
3.10300000028185E-07 |
| Stage1-vs-Stage2 |
2.065400E-01 |
| Stage1-vs-Stage3 |
5.156000E-01 |
| Stage1-vs-Stage4 |
1.389860E-02 |
| Stage2-vs-Stage3 |
5.012400E-01 |
| Stage2-vs-Stage4 |
4.924400E-01 |
| Stage3-vs-Stage4 |
1.169430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.43339999999037E-05 |
| Normal-vs-AfricanAmerican |
2.376300E-02 |
| Normal-vs-Asian |
3.632800E-04 |
| Caucasian-vs-AfricanAmerican |
7.843000E-01 |
| Caucasian-vs-Asian |
6.334200E-01 |
| AfricanAmerican-vs-Asian |
5.916600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50519999999599E-05 |
| Normal-vs-Female |
1.65046999999197E-05 |
| Male-vs-Female |
3.774800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.958300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.55630000395502E-08 |
| Normal-vs-Age(61-80Yrs) |
3.05529999999887E-06 |
| Normal-vs-Age(81-100Yrs) |
5.792800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.757300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.309700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.892600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.753800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.006300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.422400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.667000E-01 |
| Classical-VS-Follicular |
1.80650999999088E-05 |
| Classical-VS-Other |
1.757380E-01 |
| Classical-VS-Normal |
4.597800E-04 |
| Tall-VS-Follicular |
1.097770E-02 |
| Tall-VS-Other |
2.702200E-01 |
| Tall-VS-Normal |
2.593600E-02 |
| Follicular-VS-Other |
9.520000E-01 |
| Follicular-VS-Normal |
9.95699966921393E-10 |
| Other-VS-Normal |
1.164040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05629999969103E-07 |
| Normal-vs-N1 |
1.94882999999813E-05 |
| N0-vs-N1 |
7.268600E-01 |
|
|
